NO20006429L - Sammensetning som inneholder karnitin og inositolfosfat som er nyttig som kosttilskudd eller legemiddel - Google Patents

Sammensetning som inneholder karnitin og inositolfosfat som er nyttig som kosttilskudd eller legemiddel

Info

Publication number
NO20006429L
NO20006429L NO20006429A NO20006429A NO20006429L NO 20006429 L NO20006429 L NO 20006429L NO 20006429 A NO20006429 A NO 20006429A NO 20006429 A NO20006429 A NO 20006429A NO 20006429 L NO20006429 L NO 20006429L
Authority
NO
Norway
Prior art keywords
drug
composition containing
dietary supplement
inositol phosphate
containing carnitine
Prior art date
Application number
NO20006429A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006429D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20006429D0 publication Critical patent/NO20006429D0/no
Publication of NO20006429L publication Critical patent/NO20006429L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
NO20006429A 1999-04-22 2000-12-15 Sammensetning som inneholder karnitin og inositolfosfat som er nyttig som kosttilskudd eller legemiddel NO20006429L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en) 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (2)

Publication Number Publication Date
NO20006429D0 NO20006429D0 (no) 2000-12-15
NO20006429L true NO20006429L (no) 2001-02-20

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006429A NO20006429L (no) 1999-04-22 2000-12-15 Sammensetning som inneholder karnitin og inositolfosfat som er nyttig som kosttilskudd eller legemiddel

Country Status (26)

Country Link
US (1) US6565876B1 (de)
EP (1) EP1119363B1 (de)
JP (1) JP2002542282A (de)
KR (1) KR20010053023A (de)
CN (1) CN1359295A (de)
AR (1) AR023391A1 (de)
AT (1) ATE299370T1 (de)
AU (1) AU776591B2 (de)
BR (1) BR0006076A (de)
CA (1) CA2335015C (de)
DE (1) DE60021247T2 (de)
DK (1) DK1119363T3 (de)
EE (1) EE200000742A (de)
ES (1) ES2243254T3 (de)
HU (1) HU227357B1 (de)
IL (1) IL140164A0 (de)
IS (1) IS5763A (de)
IT (1) IT1306133B1 (de)
NO (1) NO20006429L (de)
PL (1) PL197885B1 (de)
PT (1) PT1119363E (de)
SI (1) SI1119363T1 (de)
SK (1) SK19322000A3 (de)
TN (1) TNSN00083A1 (de)
TR (1) TR200003737T1 (de)
WO (1) WO2000064426A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
WO2006102060A1 (en) * 2005-03-18 2006-09-28 Oxyplus, Inc. Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
EP2582368B1 (de) * 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-L-carnitin zur Erhöhung der Neurogenese in neuronalem Gewebe
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
TW202110437A (zh) * 2019-05-23 2021-03-16 美商希諾瓦有限責任公司 用於酒精誘發之皮膚潮紅之治療及緩解的組成物及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
EP1021177A4 (de) * 1997-02-04 2002-05-15 John V Kosbab Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
US6565876B1 (en) 2003-05-20
AR023391A1 (es) 2002-09-04
SI1119363T1 (en) 2005-10-31
CA2335015A1 (en) 2000-11-02
BR0006076A (pt) 2001-03-20
AU776591B2 (en) 2004-09-16
JP2002542282A (ja) 2002-12-10
ATE299370T1 (de) 2005-07-15
DE60021247T2 (de) 2006-04-27
PL197885B1 (pl) 2008-05-30
ES2243254T3 (es) 2005-12-01
HUP0102926A2 (hu) 2002-03-28
EE200000742A (et) 2002-04-15
IT1306133B1 (it) 2001-05-30
EP1119363A2 (de) 2001-08-01
HUP0102926A3 (en) 2002-12-28
SK19322000A3 (sk) 2001-06-11
ITRM990248A1 (it) 2000-10-22
KR20010053023A (ko) 2001-06-25
DE60021247D1 (de) 2005-08-18
NO20006429D0 (no) 2000-12-15
IS5763A (is) 2000-12-08
DK1119363T3 (da) 2005-10-17
AU4313500A (en) 2000-11-10
TNSN00083A1 (fr) 2005-11-10
EP1119363B1 (de) 2005-07-13
TR200003737T1 (tr) 2001-07-23
PT1119363E (pt) 2005-09-30
WO2000064426A2 (en) 2000-11-02
IL140164A0 (en) 2002-02-10
CN1359295A (zh) 2002-07-17
CA2335015C (en) 2008-03-18
PL346160A1 (en) 2002-01-28
WO2000064426A3 (en) 2001-05-25
HU227357B1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
NO20006429D0 (no) Sammensetning som inneholder karnitin og inositolfosfat anvendelig som kosttilskudd eller legemiddel
HUP0104195A3 (en) Vitamin d analogues, preparation thereof, pharmaceutical and cosmetic compositions containing them
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
HUP0100819A3 (en) Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them
EE200100618A (et) Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks
HUP0103008A3 (en) Phenoxyacetic acid derivatives and medicinal compositions containing the same
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0004226A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing thereof and process for preparing the same
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
HUP9903935A3 (en) Pharmaceutical compositions with vitamin d analogues
EE200100661A (et) Leeliselist sfingomüelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi või farmatseutilise tootena
NO20006646D0 (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
IL136612A (en) Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
HUP0003189A2 (en) Pharmaceutical composition comprising fexofenadine and its derivatives
GB9820815D0 (en) Improvementsin or relating to nutritional and pharmaceutical compositions
DK1106174T3 (da) Sammensætninger der indeholder fedtoplöselige vitaminer
EP1124438A4 (de) Nahrungsergaenzungsmittel
DK1255448T3 (da) Mælk eller mælkeprodukter tilsat carnitin
IL143800A0 (en) Halovir, an antiviral marine natural product, derivatives thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application